AI-powered telehealth startup Doccy wins 2026 Smart50 Rising Star award

Résumé détaillé

Doccy, which boasts an AI-powered pre-consultation tool, recorded $2.43 million in revenue over its first financial year. The post AI-powered telehealth startup Doccy wins 2026…

Founder: Dr Louis SiskRevenue: $2.43 millionHead office: Melbourne, AustraliaYear founded: 2025Employees: 8Industry: TechnologyWebsite: doccy.com.au

Over nine years working in surgical and emergency medicine, Dr Louis Sisk encountered a major problem. A doctor shortage meant patients in rural and regional communities could wait weeks for a GP appointment. And the healthcare professionals providing that care were approaching burnout, worsened by piles of paperwork.

Unsatisfied with existing tech platforms, he practised coding between hospital shifts to develop Doccy — a telehealth service designed to bring patients and GPs closer together, with the help of emerging tools like AI.

Along with co-founders Archer Hume and Jordi Hermoso, founder and CEO Sisk created a service capable of handling real-time consultations with accredited Australian doctors. Doccy now facilitates virtual appointments for things as simple as a medical certificate, through to prescription consultations and more general virtual check-ups.

To accelerate the process, Doccy has introduced an AI-powered pre-consultation tool, allowing patients to give their basic information ahead of time, and allowing doctors to focus on providing the right care.

By continuing, you agree to our Terms & Conditions and Privacy Policy.

Since launching in July 2025, Doccy has facilitated some 200,000 consultations, and has booked $2.43 million in revenue.

That instant traction was not guaranteed. The Doccy team first had to differentiate its AI-powered tools from off-the-shelf chatbots, which can lead patients astray with rogue recommendations and no link to actual medical professionals.

Instead, the Doccy team focused on accuracy and security within its AI-powered consultation system, while assuring patients that a real doctor remains in control of any clinical decisions.

Début de l'article, extrait de SmartCompany. Pour lire la suite, ouvrez l'article chez le média.